tiprankstipranks
Impact BioMedical, Inc. (IBO)
:IBO
US Market

Impact BioMedical, Inc. (IBO) Financial Statements

Compare
18 Followers

Impact BioMedical, Inc. Financial Overview

Impact BioMedical, Inc.'s market cap is currently ―. The company's EPS TTM is $0.089; its P/E ratio is 19.81; Impact BioMedical, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22
Income Statement
Total Revenue
Gross Profit-$ 50.00K
Operating Income$ -4.03M$ -3.40M
EBITDA$ -3.93M$ -6.30M
Net Income$ -4.41M$ -7.05M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―
Total Assets$ 44.63M$ 46.50M
Total Debt$ 12.07M$ 0.00
Net Debt$ 12.07M$ -2.00K
Total Liabilities$ 16.37M$ 13.83M
Stockholders' Equity$ ―$ ―
Cash Flow
Free Cash Flow$ -2.87M$ -2.52M
Operating Cash Flow$ -2.85M$ -2.24M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Impact BioMedical, Inc. Earnings and Revenue History

Impact BioMedical, Inc. Debt to Assets

Impact BioMedical, Inc. Cash Flow

Impact BioMedical, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis